GlassScriptPhysician profile
Erin C Radominski
NPI 1659865103
$5,199.20
in general payments reported to CMS, 2019-2025
29 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 93% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $547 · 2023: $1,869 · 2024: $1,078 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,389 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,388.52 |
| Education | $160.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,105.44 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $856.07 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $604.15 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $529.03 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.20 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $213.04 | 2022-2025 | Tezspire, Tavneos |
| Axsome Therapeutics, INC. | $191.55 | 2022-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $161.80 | 2023-2025 | Glassia |
| Actelion Pharmaceuticals US, INC. | $147.79 | 2023 | Opsumit, Uptravi |
| Insmed, INC. | $136.69 | 2024-2025 | Arikayce |
| Grifols USA, LLC | $126.80 | 2022-2025 | Prolastin-C Liquid |
| Lilly USA, LLC | $114.12 | 2025 | Zepbound |
| United Therapeutics Corporation | $76.38 | 2023-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $73.34 | 2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $70.32 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $61.99 | 2023 | |
| Baxter Healthcare | $61.69 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $52.84 | 2023-2025 | Vest Therapy Und |
| Mylan Specialty L.P. | $46.09 | 2023-2024 | Yupelri |
| Pharming Healthcare, INC. | $43.53 | 2023 | Ruconest |
| Merck Sharp & Dohme LLC | $39.96 | 2023 | |
| Inspire Medical Systems, INC. | $33.95 | 2025 | Inspire |
| Shionogi INC | $28.62 | 2022 | |
| Genentech USA, INC. | $20.82 | 2023 | Xolair |
| Melinta Therapeutics, LLC | $18.19 | 2024 | Rezzayo, Vabomere |
| Inogen, INC. | $17.68 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $17.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.30 | 2023 | |
| Jazz Pharmaceuticals INC. | $13.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Radominski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.